Senate Panel Targets 'Clever' Pharma Pricing <https://www.law360.com/competition/articles/2062462?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-10-30&read_main=1&nlsidx=0&nlaidx=11> By Mark Payne The Senate Judiciary Committee on Tuesday railed against drugmakers and pharmacy benefit managers for allegedly causing the high cost of prescription drugs, arguing that "Big Pharma" has used anticompetitive tactics through patenting to fleece American patients. Read full article » <https://www.law360.com/competition/articles/2062462?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-10-30&read_more=1&nlsidx=0&nlaidx=11> | Save to favorites » <https://www.law360.com/competition/articles/2062462?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-10-30&read_later=1&nlsidx=0&nlaidx=11>